|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
956,580,000 |
Market
Cap: |
851.46(B) |
Last
Volume: |
2,877,071 |
Avg
Vol: |
3,271,395 |
52
Week Range: |
$434.7 - $891.46 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 720 |
Guru Rank Value : 1.4 |
Guru Occurances : 2 |
|
|
|
|
|
|
|
Company Profile Eli Lilly and Company discovers, develops, manufactures, and markets products in a single business segment: human pharmaceutical products. Co.'s products include: diabetes products, oncology products, immunology products, neuroscience products, and other therapies. Co.'s diabetes products include: Baqsimi®, Basaglar®, Humalog®, Humulin®, Jardiance®, Lyumjev®, Trajenta®, and Trulicity®. Co.'s oncology products include: Alimta®, Cyramza®, Erbitux®, Retevmo®, Tyvyt®, and Verzenio®. Co.'s immunology products include: Olumiant® and Taltz®. Co.'s neuroscience products include: Cymbalta®, Emgality®, Reyvow®, and Zyprexa®. Co.'s other therapies include: Bamlanivimab, Cialis®, and Forteo®.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) ![](../../images/information.jpg) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
656 |
Total Buy Value |
$0 |
$0 |
$0 |
$199,549 |
Total People Bought |
0 |
0 |
0 |
1 |
Total Buy Transactions |
0 |
0 |
0 |
1 |
Total Shares Sold |
1,332,477 |
2,203,227 |
3,639,104 |
6,172,895 |
Total Sell Value |
$1,114,649,593 |
$1,722,900,173 |
$2,147,483,647 |
$2,147,483,647 |
Total People Sold |
3 |
3 |
4 |
6 |
Total Sell Transactions |
17 |
30 |
51 |
94 |
End Date |
2024-03-26 |
2023-12-24 |
2023-06-25 |
2022-06-25 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Lilly Endowment Inc |
10% Owner |
|
2020-07-09 |
4 |
S |
$169.68 |
$2,199,392 |
D/D |
(12,961) |
111,132,343 |
|
16% |
|
Lilly Endowment Inc |
10% Owner |
|
2020-07-07 |
4 |
S |
$167.15 |
$35,131,799 |
D/D |
(210,000) |
111,145,304 |
|
16% |
|
Lilly Endowment Inc |
10% Owner |
|
2020-07-06 |
4 |
S |
$166.46 |
$34,232,086 |
D/D |
(205,000) |
111,655,304 |
|
15% |
|
Pusey Leigh Ann |
SVP, Corp. Affairs & Comm. |
|
2020-07-05 |
4 |
D |
$163.87 |
$182,551 |
D/D |
(1,114) |
4,310 |
|
- |
|
Pusey Leigh Ann |
SVP, Corp. Affairs & Comm. |
|
2020-07-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,468 |
5,424 |
|
- |
|
Lilly Endowment Inc |
10% Owner |
|
2020-06-30 |
4 |
S |
$163.20 |
$27,227,760 |
D/D |
(166,832) |
111,560,304 |
|
11% |
|
Lilly Endowment Inc |
10% Owner |
|
2020-06-29 |
4 |
S |
$163.36 |
$1,867,760 |
D/D |
(11,431) |
111,727,136 |
|
13% |
|
Lilly Endowment Inc |
10% Owner |
|
2020-06-26 |
4 |
S |
$163.01 |
$5,173,404 |
D/D |
(31,737) |
111,738,567 |
|
12% |
|
Lilly Endowment Inc |
10% Owner |
|
2020-06-18 |
4 |
S |
$160.88 |
$8,686,046 |
D/D |
(53,770) |
111,770,304 |
|
18% |
|
Lilly Endowment Inc |
10% Owner |
|
2020-06-17 |
4 |
S |
$160.90 |
$26,019,469 |
D/D |
(161,230) |
111,824,074 |
|
18% |
|
Zulueta Alfonso G |
SVP & President, Lilly Intl |
|
2020-06-16 |
4 |
AS |
$160.00 |
$2,770,000 |
D/D |
(17,000) |
29,646 |
|
-19% |
|
Lilly Endowment Inc |
10% Owner |
|
2020-06-16 |
4 |
S |
$158.54 |
$34,593,145 |
D/D |
(212,337) |
111,985,304 |
|
19% |
|
Tai Jackson P |
Director |
|
2020-06-15 |
4 |
A |
$141.52 |
$1,981 |
D/D |
14 |
58,276 |
|
- |
|
Zulueta Alfonso G |
SVP & President, Lilly Intl |
|
2020-06-05 |
4 |
AS |
$150.00 |
$1,500,000 |
D/D |
(10,000) |
46,646 |
|
-2% |
|
Tai Jackson P |
Director |
|
2020-05-18 |
4 |
A |
$157.96 |
$1,896 |
D/D |
12 |
58,200 |
|
- |
|
Lilly Endowment Inc |
10% Owner |
|
2020-04-27 |
4 |
S |
$163.60 |
$2,071,715 |
D/D |
(12,663) |
112,197,641 |
|
6% |
|
Lilly Endowment Inc |
10% Owner |
|
2020-04-24 |
4 |
S |
$161.22 |
$35,743,218 |
D/D |
(220,000) |
112,210,304 |
|
7% |
|
Lilly Endowment Inc |
10% Owner |
|
2020-04-23 |
4 |
S |
$159.36 |
$36,826,587 |
D/D |
(230,000) |
112,430,304 |
|
6% |
|
Tai Jackson P |
Director |
|
2020-04-20 |
4 |
A |
$157.79 |
$1,893 |
D/D |
12 |
58,188 |
|
- |
|
Shah Aarti S. |
SVP & CIO |
|
2020-04-14 |
4 |
AS |
$150.00 |
$300,000 |
D/D |
(2,000) |
19,087 |
|
2% |
|
Lilly Endowment Inc |
10% Owner |
|
2020-04-09 |
4 |
S |
$145.14 |
$33,445,542 |
D/D |
(230,000) |
112,660,304 |
|
-5% |
|
Lilly Endowment Inc |
10% Owner |
|
2020-04-07 |
4 |
S |
$142.70 |
$24,676,281 |
D/D |
(172,315) |
112,890,304 |
|
-7% |
|
Lilly Endowment Inc |
10% Owner |
|
2020-04-06 |
4 |
S |
$142.73 |
$2,278,322 |
D/D |
(15,962) |
113,062,619 |
|
-6% |
|
Lilly Endowment Inc |
10% Owner |
|
2020-04-03 |
4 |
S |
$143.04 |
$3,826,493 |
D/D |
(26,723) |
113,078,581 |
|
-6% |
|
Lilly Endowment Inc |
10% Owner |
|
2020-04-02 |
4 |
S |
$140.46 |
$23,374,654 |
D/D |
(166,038) |
113,105,304 |
|
-7% |
|
1436 Records found
|
|
Page 23 of 58 |
|
|